参考文献/References:
[1]Xia SJ,Zhou CX,Kalionis B,et al.Combined antioxidant,anti-inflammaging and mesenchymal stem cell treatment:a possible therapeutic direction in elderly patients with chronic obstructive pulmonary disease[J].Aging and Disease,2020,11(1):129-140.
[2]Zhang HL,Li JS,Yu XQ,et al.Effects of Chinese medicine on patients with acute exacerbations of COPD:study protocol for a randomized controlled trial[J].Trials,2019,20(1):735.
[3]中华中医药学会内科分会肺系病专业委员会.慢性阻塞性肺疾病中医证候诊断标准(2011版)[J].中医杂志,2012,53(2):177-178.
[4]蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2017GOLD报告)解读[J].国际呼吸杂志,2017,37(1)：6-17.
[5]Stolz D,Barandun J,Borer H,et al.Diagnosis,prevention and treatment of stable COPD and acute exacerbations of COPD:the Swiss recommendations 2018[J].Respiration,2018,96(4):382-398.
[6]夏逸飞,孙子凯.哮喘-慢阻肺重叠的中医辨治思路[J].湖南中医药大学学报,2019,39(5):619-622.
[7]赵小寅,郭秀君,孟亚慧,等.三伏贴治疗慢性阻塞性肺疾病临床疗效与皮肤过敏反应相关性研究[J].江苏中医药,2019,51(4):31-34.
[8]刘振坤,乔明涛,安瑞肖,等.PCT、YKL-40、sICAM-1、TRAIL和IP-10联合检测在慢性阻塞性肺疾病气道炎症中的诊断意义[J].实用医院临床杂志,2019,16(1):176-180.
[9]邓清洋,孙建,冯晓丽,等.COPD患者血清炎症指标与气道炎症的关系[J].西部医学,2020,32(1):69-72.
[10]Li H,Shi KH,Zhao Y,et al.TIMP-1 and MMP-9 expressions in COPD patients complicated with spontaneous pneumothorax and their correlations with treatment outcomes[J].Pakistan Journal of Medical Sciences,2019,36(2):192.DOI:10.12669/pjms.36.2.1244.
[11]Shen DD,Yang ZH,Huang J,et al.Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1[J].Pharmaceutical Biology,2019,57(1):744-752.
[12]Arbaningsih SR,Syarani F,Ganie RA,et al.The levels of vitamin D,metalloproteinase-9 and tissue inhibitor metalloproteinase-1 in COPD patients,healthy smokers and non-smokers of Indonesian citizens[J].Open Access Macedonian Journal of Medical Sciences,2019,7(13):2123-2126.
[13]徐燕玲,霍莉莉,武艺林,等.儿童反复呼吸道感染外治方案优化研究[J].中国中医药信息杂志,2019,26(8):35-39.
[14]张兰英,陈杰,张奕,等.慢性阻塞性肺疾病患者肺组织中树突状细胞、辅助性T细胞17/调节性T细胞的表达及其意义[J].中华内科杂志,2019,58(2):125-132.
[15]赵晓丽,唐树荣,王司辰,等.COPD合并细菌感染患者的外周血免疫细胞变化[J].昆明医科大学学报,2019,40(3):49-52.
[16]郝文东,郎华,李晓婧,等.玉屏风颗粒联合厚朴排气合剂治疗气虚腑实型稳定期COPD疗效及对免疫功能、CX3CL1与MFAP-4的影响[J].现代中西医结合杂志,2020,29(9):918-922.
[17]杨益宝,冯玉清,梁爱武,等.银杏叶提取物对慢性阻塞性肺疾病大鼠T细胞亚群的影响[J].中国中西医结合杂志,2018,38(7):851-854.
[18]叶娟.信必可都保联合噻托溴铵治疗对COPD合并支气管哮喘患者肺功能、免疫功能及气道阻力的影响[J].标记免疫分析与临床,2019,26(2):264-268,289.
[19]及孟,李光智,余洪,等.保元汤加味对心阳虚衰型冠心病心力衰竭患者血清hs-CRP及心功能的影响[J].辽宁中医杂志,2019,46(7):1437-1440.
[20]张秀荣,薛一涛.真武汤合保元汤对2型心肾综合征阳气亏虚证兼血瘀证心肾功能的影响[J].中国实验方剂学杂志,2018,24(9):202-207.